:::2nd annual biobank china 2012 ethics construction & information management for biobank:::-ag凯发旗舰厅

home   |   overview   |   speakers   |   organizers   |   agenda   |   registration   |      |   venue & hotel   |   contacts   |   简体中文版
 
 

agenda

 
registration:
july 5, 2012        thursday        1st floor, shanghai san want hotel
14:00-20:00 all attendees registration
july 6, 2012        friday        2nd floor, shanghai san want hotel
08:00-17:00 all attendees registration
 
opening ceremony:
july 6, 2012        friday morning
08:30 welcome speech chairmen
 
agenda:
july 6, 2012    friday    2nd floor, shanghai san want hotel
biobank management and translational medical research

session 1: biobank construction & translational medical research
nowadays, critical diseases such as tumour, metabolic diseases, mental, neurological and chronic diseases, become increasing threat to our health, while to cure these diseases people need to realize early diagnosis, molecular classification and personalized medicine. the progress in translational medical research and personalized research depends on the quantity and quality of clinical biospecimen. we invite renowned experts to introduce the practices in biobank and translational medical research cases.

09:00  the effects of tissue biobank on
             translational medical research

kurt zatloukal
coordinator of bbmri, professor of pathology, institute of pathology, medical university of graz

09:25  the influence of laws and regulations on the application of chinese bio-samples
guoping zhao
academician of cas, researcher of shanghai institutes for biological sciences, cas

09:50  construction and development of national critical disease biobank
peng wang
professor of peking union medical college hospital

10:15  tea break

10:35  how biobanking is advancing personalized medicine
conny mathay
biorefinery scientist, integrated biobank of luxembourg (ibbl)

11:00  construction and application of metabolic disease biobank
congrong wang
committee member of advisory committee of national biobank for critical diseases

11:25  q&a

session 2: best practices of biobanks and low temperature storage(lts)
the construction of biobank is a comprehensive project involves fund, location, organization, staff, equipment, information system, quality assurance, security management, ethics, and the collection, handling and storage of biospecimen. lts is one of the most important technologies. the conference will discuss best practices and lts technology in the construction of biobank.

13:00  the best practice of obbr on biobanking
jim vaught
deputy director in nci-obbr

13:25  current best practices in biosample management
rhett affleck
sr. director of applications and product management, brooks’ life science systems division

13:50  lts and the preservation of biospecimen
zhanjie liu
professor of qingdao university, general manger of qingdao haier special electric appliance co. ltd.

14:15  biospecimen lts and solutions
xinle niu
post doctorate of harvard, marketing manager of life sciences, laboratory product group, thermofisher, china

14:40  q&a
14:55  tea break
ethics construction for biobank

session 1: access rules and informed consent
with the development of genome, proteome and genome sequence, the tracing of biobank data depends on electronic database and database based on internet. it is urgent to control the risk of privacy violation and thus draft orderly biobank access rules. we will introduce the current exemplary access rules and we will also learn about informed consent on the conference.

15:10  access rules within biobank networks
georges dagher
deputy director, clinical research dpt, inserm, paris; leader of funding & financing at bbmri

15:30  access rule- the key to privacy protection and data safety
ingrid schneider
professor of research centre for biotechnology, society and the environment, university of hamburg

15:50  "informed consent" in establishment of chinese different ethnic groups' immortalized cell line bank
jiayou chu
professor of chinese academy of medical sciences

16:10  informed consent model within biobanking
wei zhu
associate professor of the center for applied ethics and department of social sciences, fudan university

16:30  q&a
 
july 7, 2012    saturday    2nd floor, shanghai san want hotel
ethics construction for biobank

session 2: current situation and policy analysis
in 2009, times selected biospecimen repository one of the ten concepts changing the world and countries have all started to construction large-scale biobanks. what is the current situation in china and in shanghai? what policy shall we adopt to promote the development? we will bring you the latest information and different interpretation and suggestions on this issue.

08:30  suggestions and reflections on shanghai clinical biobank ethics construction
ching-li hu
professor, member of the unesco international bioethics committee

08:50  analysis of ethical issues in biobank networks
renzong qiu
researcher of institute of philosophy, cass

09:10  ethical policies of german biobank
regine kollek
director of research centre for biotechnology, society and the environment, university of hamburg, member of german national ethics council

09:30  prospects of biobank construction regulation and life science ethical study
kan zhang
director, department of scientific research & education, shanghai municipal health bureau

09:50  tea break

10:10  ethical guidelines and policies in biobanking in europe
anne cambon-thomsen
director of ethics committee, cnrs; genomics and public health, inserm

10:30  current situation and policy suggestions on chinese biobank construction
xiaomei zhai
professor and director, center for bioethics, chinese academy of medical sciences

10:50  ethical policies and guidelines in biobanking in obbr
chana rabiner
project manager and international project coordinator of national institutes of health (nih)

11:10  q&a
information management for biobank

session 1: information management system of biobank
information management system of biobank plays an important role in the construction of biobank, appropriate system would simplify the working procedure, enhance the efficiency, and prevent information leakage and protect the donor’s privacy. how to use the information management system to collect biospecimen and realize the link between equipment and his/lis system? how to conduct management and check of biospecimen and donor information and how to ensure information security? we will share the latest concept and solution with you.

13:00  iso 27001 application in information management of biospecimen and safety protection of information
paul downey
director of operations, uk biobank

13:25  application of information system in biobank
john mccall
director of biospecimen repository, laboratory of clinical infectious disease, niaid, nih

13:50  construction of information management system in xinhua hospital
weiye wang
director of the biobank for xinhua hospital affiliated to shanghai jiao tong university

14:15  information construction of national gene bank
yong zhang
head of proteomics division at bgi shenzhen, project director at bgi shenzhen

14:40  tea break

session 2: information network and sharing system of biobank
how to promote the construction of biobank information system and enhance the information exchange between biobank collector and user to realize the unified management and publish of information are the premise of biobank sharing system and the problems confronted by all the countries. we invite experts of biobank information network from the u.s., europe and china to share with you their experience.

15:00  the development and application informatics systems for biobanking at the us national cancer institute
ian fore
director, biospecimen and pathology informatics, nci center for biit

15:25  cross-biobank data integration and harmonization
maria krestyaninova
senior scientist at the institute for molecular medicine finland

15:50  construction of sharing and coordination network of biobank resources
yougang miao
vice director of shanghai information center for life science, cas

16:15  q&a

16:45  closing speech
rongxing gan
director of shanghai clinical research center

 
 
ag凯发旗舰厅 copyright 2012        shanghai clinical research center        all rights reserved
网站地图